PALIPERIDONE ER TREATMENT AND THE IMPROVEMENT OF SOCIAL AND COGNITIVE FUNCTION IN PATIENTS WITH SCHIZOPHRENICS - A 24-WEEK, SINGLE ARM, OPEN-LABEL STUDY

被引：2
|
作者：
Shi, Chuan [1 ]
Yu, Xin [1 ]
Kang, Lan [1 ]
Yao, Shuqiao [2 ]
Tang, Xirong [2 ]
Xu, Yifeng [3 ]
Peng, Daihui [3 ]
Shi, Jianguo [4 ]
Lin, Huali [4 ]
Xu, Xiufeng [5 ]
Liu, Fang [5 ]
Zhang, Congpei [6 ]
Wang, Xijin [6 ]
机构：
[1] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China
[2] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[3] Shanghai Jiao Tong Univ, Inst Mental Hlth, Shanghai, Peoples R China
[4] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China
[5] Kunming Med Sch, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[6] First Haerbin Psychiat Hosp, Harbin, Heilongjiang, Peoples R China
来源：
SCHIZOPHRENIA RESEARCH | 2014年 / 153卷
关键词：
D O I：
10.1016/S0920-9964(14)70362-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
S83
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [41] Cyclosporine in treatment of progressive vitiligo: An open-label, single-arm interventional study
    Taneja, Atul
    Kumari, Asha
    Vyas, Kapil
    Khare, Ashok Kumar
    Gupta, Lalit Kumar
    Mittal, Asit Kumar
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2019, 85 (05): : 528 - +
  • [42] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
  • [43] Quality of Life in 833 outpatients with major depression treated with open-label venlafaxine extended release: An observational 24-week study
    Cervera-Enguiz, S
    Soutullo, CA
    Landecho, I
    Murillo-Jelsbak, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 193 - 197
  • [44] Long-term treatment with the NMDA antagonist, memantine:: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease
    Ferris, SH
    Schmitt, FA
    Doody, R
    Möbius, HJ
    Stöffler, A
    Reisberg, B
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 258 - 259
  • [45] Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study
    Si, Tianmei
    Zhang, Kerang
    Tang, Jisheng
    Fang, Maosheng
    Li, Keqing
    Zhuo, Jianmin
    Feng, Yu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1483 - 1492
  • [46] Ideal: A 28-week open-label extension of a 24-week double-blind study of the first transdermal patch in Alzheimer's disease
    Froelich, L.
    Barone, P.
    Foerstl, H.
    Onofrj, M.
    Nagel, J.
    Ros, J.
    Tekin, S.
    Orgogozo, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 48 - 49
  • [47] An open-label, multicentre, 24-week, exploratory study to assess the efficacy and safety of dimethyl fumarate in patients with moderate plaque psoriasis: patient baseline characteristics
    Warren, R. B.
    Atwan, A.
    Skov, L.
    Cooper, H.
    Pink, A.
    Foulkes, A. C.
    Kirby, B.
    Everiss, T.
    Pau-Charles, I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E92 - E93
  • [48] Rovadicitinib in Patients with Hemophagocytic Lymphohistiocytosis: A Single Arm, Open-Label, Phase I Study
    Wang, Zhao
    Wang, Jingshi
    Wu, Lin
    Song, Deli
    Pi, Yubo
    Ding, Dawei
    Chen, Yao
    Wang, Xunqiang
    BLOOD, 2024, 144 : 806 - 807
  • [49] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
    Harari, Sergio
    Elia, Davide
    Caminati, Antonella
    Geginat, Jens
    Luisi, Francesca
    Pelosi, Giuseppe
    Specchia, Claudia
    Torre, Olga
    Trevisan, Roberta
    Vasco, Chiara
    Zompatori, Maurizio
    Cassandro, Roberto
    LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
  • [50] The efficacy and safety of milnacipran in patients with major depressive disorder following initial treatment failure with a selective serotonin reuptake inhibitor: a pragmatic 24-week, multicentre, open-label study
    Tasuku, Hashimoto
    Oda, Yasunori
    Hasegawa, Tadashi
    Kanahara, Nobuhisa
    Sasaki, Tsuyoshi
    Komatsu, Hideki
    Takahashi, Junpei
    Oiwa, Takahiro
    Sakashita, Kiyoshi
    Ishima, Tamaki
    Takase, Naoko
    Kikuchi, Shuichi
    Sekine, Yoshimoto
    Hashimoto, Kenji
    Lyo, Masaomi
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 35 - 36
12345